Multigen 2
Payments companies reported to CMS as associated with Multigen 2. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Multigen 2, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Multigen 2
These are the largest totals companies reported as associated with Multigen 2. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Akhil Chhatre | Baltimore, MD | Physical Medicine & Rehabilitation | $37,032.99 |
| Zachary Mccormick | Chicago, IL | Physical Medicine & Rehabilitation | $24,661.09 |
| Douglas Beall | Edmond, OK | Diagnostic Radiology | $23,121.91 |
| Wayne Olan | Washington, DC | Neuroradiology | $19,139.41 |
| Jason Dunleavy | Williamsville, NY | Diagnostic Radiology | $15,033.43 |
| Jad Khalil | Southfield, MI | Orthopaedic Surgery | $13,650.00 |
| Majid Khan | Baltimore, MD | Neuroradiology | $8,075.00 |
| Jack Jennings | Saint Louis, MO | Diagnostic Radiology | $7,716.87 |
| Nathan Neufeld | Newnan, GA | Interventional Pain Medicine | $6,800.00 |
| James Morrison | Grand Rapids, MI | Diagnostic Radiology | $5,554.21 |
Prescribed Multigen 2?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.